Medical News

RSS

£3 million funding to support the development of new antimicrobials for cystic fibrosis patients

Today (16 March 2023), Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) announces a £3 million Collaborative Discovery Programme for drug discovery innovators to accelerate the development of new treatments for people with CF.

20 Mar 2023

New WHO report identifies five core national targets for managing diabetes

A new report for the World Health Organization has identified five core national targets for UN member states aimed at reducing diabetes risk and ensuring that people with diabetes have equitable access to comprehensive and affordable care and prevention.

20 Mar 2023

Female rheumatoid arthritis patients taking sex hormones have greater chance of achieving remission

A large study of women with rheumatoid arthritis has found that those taking oral contraceptives or hormone replacement therapy (HRT) had a greater chance of achieving remission.

20 Mar 2023

New SARS-CoV-2 Omicron XBB.1.5 variant has high transmissibility and infectivity, study finds

COVID-19 has caused significant global panic after its rapid emergence more than 3 years ago. Although we now have highly effective vaccines against the SARS-CoV-2 virus, which causes COVID-19, scientists continue to study emerging SARS-CoV-2 variants in order to safeguard public health and devise global preventive strategies against emerging variants.

20 Mar 2023

H5N1 avian influenza found in stranded harbor porpoise

In a recent study published in the United States (U.S.) Centers for Disease Control and Prevention (CDC) journal Emerging Infectious Diseases, researchers from Sweden described the detection of the hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza virus in a stranded harbor porpoise, indicating a potential spillover of this highly pathogenic avian influenza virus into cetacean species.

20 Mar 2023

How does a vegan diet affect the performance of bodybuilders?

A new study in the International Journal of Environmental Research and Public Health aimed to compare the nutritional intakes of vegan and omnivorous bodybuilders at different stages of preparation for a bodybuilding competition.

19 Mar 2023

What role does dysbiosis play in Parkinson's disease?

The current study, published in the journal Revue Neurologique, is based on the hypothesis that dysbiosis, or unhealthy variations in the gut and oral microbiota, is a key component of PD pathogenesis.

19 Mar 2023

XBB/XBB.1.5 subvariant of SARS-CoV-2 shows increased vaccine sensitivity

The study, currently available on the medRxiv* preprint server, indicates that omicron subvariant XBB/XBB.1.5 is more sensitive to vaccine-induced immunity than other co-circulating SARS-CoV-2 variants.

19 Mar 2023

How does sleep loss affect children's health?

The understanding of the impact of disturbed sleep on health-related quality of life (HRQOL) among healthy children is quite limited. To address this gap, a new JAMA Network Open study aimed to research the effect of sleep deprivation on HRQOL in healthy children without major sleep issues.

19 Mar 2023

Gut microbiomes and mental health: how do they interact?

A new study published in the journal Frontiers in Medicine reviewed recent literature on the link between gut microbiota, the brain, and neurological disorders.

19 Mar 2023

Inadequate sleep associated with lower vaccine-induced humoral immunity

Researchers assess the association between the duration of sleep and humoral responses to vaccination.

19 Mar 2023

Biomarkers that can predict long COVID symptoms

The current study offered novel insights into the different biological factors that might contribute to long COVID.

19 Mar 2023

Machine learning applications for the diagnosis, treatment and prognosis of cancer

Researchers review the application of machine learning in improving cancer diagnosis, treatment, and prognosis.

19 Mar 2023

California picks generic drug company Civica to produce low-cost insulin

Gov. Gavin Newsom on Saturday announced the selection of Utah-based generic drug manufacturer Civica to produce low-cost insulin for California, an unprecedented move that makes good on his promise to put state government in direct competition with the brand-name drug companies that dominate the market.

19 Mar 2023